FDA
approval
· 2024-12-23
FDA Approved: CARDIOGEN-82 — Supplemental Application (Bracco Diagnostics Inc)
Summary
The FDA approved a supplemental application for CardioGen-82 (rubidium chloride RB-82) submitted by Bracco Diagnostics Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CARDIOGEN-82 (RUBIDIUM CHLORIDE RB-82)